Cetera Investment Advisers
TECH icon

Cetera Investment Advisers’s Bio-Techne TECH Stock Holding History

Cetera Investment Advisers’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.8M Buy
39,638
+841
+2% +$45.4K ﹤0.01% 2102
2026
Q1 		$2.03M Buy
38,797
+5,906
+18% +$355K ﹤0.01% 2271
2025
Q4 		$1.93M Sell
32,891
-868
-3% -$52.7K ﹤0.01% 2237
2025
Q3 		$1.88M Buy
33,759
+17,043
+102% +$913K ﹤0.01% 2229
2025
Q2 		$860K Buy
16,716
+1,356
+9% +$68.1K ﹤0.01% 2514
2025
Q1 		$901K Sell
15,360
-4,497
-23% -$305K ﹤0.01% 2349
2024
Q4 		$1.43M Sell
19,857
-887
-4% -$65.1K ﹤0.01% 1903
2024
Q3 		$1.66M Sell
20,744
-2,769
-12% -$208K ﹤0.01% 1759
2024
Q2 		$1.68M Buy
23,513
+90
+0.4% +$6.62K ﹤0.01% 1702
2024
Q1 		$1.65M Buy
23,423
+13,474
+135% +$964K ﹤0.01% 1699
2023
Q4 		$768K Sell
9,949
-1,199
-11% -$79K 0.01% 1256
2023
Q3 		$759K Buy
11,148
+1,146
+11% +$90.5K 0.01% 1192
2023
Q2 		$816K Buy
10,002
+1,126
+13% +$90.5K 0.01% 1155
2023
Q1 		$659K Buy
8,876
+81
+0.9% +$6.24K 0.01% 1260
2022
Q4 		$729K Buy
8,795
+3,575
+68% +$284K 0.01% 1151
2022
Q3 		$371K Sell
5,220
-548
-10% -$47.4K 0.01% 1145
2022
Q2 		$500K Buy
5,768
+52
+0.9% +$4.87K 0.01% 1099
2022
Q1 		$619K Sell
5,716
-232
-4% -$23.9K 0.01% 1030
2021
Q4 		$769K Sell
5,948
-5,572
-48% -$683K 0.01% 926
2021
Q3 		$1.4M Buy
11,520
+5,320
+86% +$647K 0.02% 647
2021
Q2 		$698K Buy
6,200
+3,424
+123% +$360K 0.01% 935
2021
Q1 		$265K Sell
2,776
-3,428
-55% -$313K 0.01% 1317
2020
Q4 		$493K Buy
+6,204
New +$449K 0.01% 972

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.3B AUM 67.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Cetera Investment Advisers's TECH Position: Q2 2026 in Review

Cetera Investment Advisers increased its Bio-Techne (TECH) stake by 2.2% in Q2 2026, buying an estimated $45.4K and bringing the position to 39,638 shares worth $2.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2102.

Cetera Investment Advisers first reported a position in TECH in Q4 2020 and has held it in 23 quarters since. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Cetera Investment Advisers held 39,638 shares of Bio-Techne worth $2.8M as of Q2 2026.
  • Cetera Investment Advisers bought 841 Bio-Techne shares in Q2 2026, an estimated $45.4K.
  • Bio-Techne made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #2102 holding.
  • Cetera Investment Advisers first reported a position in Bio-Techne in Q4 2020 and has held it in 23 quarters since.
  • 596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.